<DOC>
	<DOCNO>NCT02705625</DOCNO>
	<brief_summary>This multicentre , randomise , placebo-controlled , double-blind , three-arm parallel , Phase IIa study evaluate efficacy , safety tolerability MIV-711 patient knee osteoarthritis ( OA ) .</brief_summary>
	<brief_title>A Study Evaluate Efficacy , Safety Tolerability MIV-711 Osteoarthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Current average knee pain , define pain either knee , within 1 week visit 1 , patient give severity score â‰¥4 , &lt; 10 010 NRS ( Numeric Rating Scale ) . Inclusive 4080 year old . Diagnosis primary knee osteoarthritis The presence inflammatory arthritis Any generalize pain condition may interfere evaluation target knee pain ( e.g. , fibromyalgia ) judge investigator . Any clinically severe significant uncontrolled concurrent illness , , opinion Investigator , would impair ability give inform consent take part complete clinical study . Known suspect intolerance hypersensitivity investigational product , closely related compound , state ingredient .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>